Ipamorelin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support. Common dosages range from 200-300 mcg administered 2-3 times daily. Below are the most frequently asked questions.
Frequently Asked Questions About Ipamorelin
What is Ipamorelin?
Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic. Synthetic pentapeptide derived from GHRP-1, engineered for selective GH release. It is researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.
What is the recommended Ipamorelin dosage?
Common dosages range from 200-300 mcg, administered 2-3 times daily via subcutaneous injection. Cycles typically run 8-12 weeks, often stacked with CJC-1295.
What are the side effects of Ipamorelin?
Minimal side effects compared to other GH secretagogues. Mild headache, light-headedness, or injection site reactions possible. Does not cause the intense hunger seen with GHRP-6 or the cortisol/prolactin spikes seen with GHRP-2.
Is Ipamorelin legal?
Not FDA-approved. Research chemical. Banned by WADA.
What is the half-life of Ipamorelin?
The half-life of Ipamorelin is approximately 2 hours, which determines the 2-3 times daily dosing schedule.
How do you reconstitute Ipamorelin?
Add bacteriostatic water to the lyophilized Ipamorelin vial. Let the water run down the side — never spray on the powder. Swirl gently. Use our peptide calculator for exact amounts.
Can you stack Ipamorelin with other peptides?
Best paired with CJC-1295 no DAC for synergistic GH release — the GHRH + GHRP combination amplifies GH pulse amplitude beyond what either achieves alone. This is the most widely recommended beginner GH peptide stack.
Where can you buy Ipamorelin?
Ipamorelin is available as a research chemical from vetted suppliers with third-party COA testing.
How long does it take Ipamorelin to work?
Initial effects may be noticed within 1-2 weeks, with more significant results typically appearing by weeks 4-8 of a 8-12 weeks, often stacked with CJC-1295 cycle.
What makes Ipamorelin unique?
The most selective GH secretagogue available — the only GHRP that doesn't meaningfully raise cortisol, prolactin, or appetite at therapeutic doses, making it the safest entry point for GH optimization.
Complete Guide
Ipamorelin: The Cleanest GH Secretagogue
Related Reading
- Ipamorelin Dosage Guide
- Ipamorelin Benefits
- Ipamorelin Side Effects
- Ipamorelin Stacking Guide
- Ipamorelin Cycle Guide
- Ipamorelin Research
Calculate Your Ipamorelin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Ipamorelin.
Open Calculator →Research-Grade Sourcing
If you're going to research Ipamorelin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic. Synthetic pentapeptide derived from GHRP-1, engineered for selective GH release. It is researched for growth hormone release, improved sleep, fat loss, muscle recovery, bone density support.
What is the recommended Ipamorelin dosage?
Common dosages: 200-300 mcg administered 2-3 times daily via subcutaneous injection. Cycle length: 8-12 weeks, often stacked with CJC-1295. Half-life: approximately 2 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of Ipamorelin?
Minimal side effects compared to other GH secretagogues. Mild headache, light-headedness, or injection site reactions possible. Does not cause the intense hunger seen with GHRP-6 or the cortisol/prolactin spikes seen with GHRP-2.
Is Ipamorelin safe?
Ipamorelin has shown a preliminary safety profile in research. Not FDA-approved. Research chemical. Banned by WADA. All research should follow appropriate safety protocols.